NCT03567785View on ClinicalTrials.gov

Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

February 10, 2021

Study Completion Date

February 11, 2021

Conditions
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

KU Leuven

OTHER

NCT03567785 - Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter